Medicom Conference Report EHA 2023最新文献

筛选
英文 中文
Investigational agent OMS906 performs well in PNH 研究用药OMS906在PNH中表现良好
Medicom Conference Report EHA 2023 Pub Date : 2023-08-02 DOI: 10.55788/7aace467
Robert van den Heuvel
{"title":"Investigational agent OMS906 performs well in PNH","authors":"Robert van den Heuvel","doi":"10.55788/7aace467","DOIUrl":"https://doi.org/10.55788/7aace467","url":null,"abstract":"","PeriodicalId":196013,"journal":{"name":"Medicom Conference Report EHA 2023","volume":"47 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128328056","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Can we combine teclistamab and nirogacestat for the treatment of RRMM? 特司他单抗和硝格司他联合治疗RRMM是否可行?
Medicom Conference Report EHA 2023 Pub Date : 2023-08-02 DOI: 10.55788/01a5d59b
Robert van den Heuvel
{"title":"Can we combine teclistamab and nirogacestat for the treatment of RRMM?","authors":"Robert van den Heuvel","doi":"10.55788/01a5d59b","DOIUrl":"https://doi.org/10.55788/01a5d59b","url":null,"abstract":"","PeriodicalId":196013,"journal":{"name":"Medicom Conference Report EHA 2023","volume":"53 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121665857","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
REVIVE: Rusfertide meets the primary endpoint in PV REVIVE: Rusfertide满足PV中的主要终点
Medicom Conference Report EHA 2023 Pub Date : 2023-08-02 DOI: 10.55788/3975ae9c
Robert van den Heuvel
{"title":"REVIVE: Rusfertide meets the primary endpoint in PV","authors":"Robert van den Heuvel","doi":"10.55788/3975ae9c","DOIUrl":"https://doi.org/10.55788/3975ae9c","url":null,"abstract":"","PeriodicalId":196013,"journal":{"name":"Medicom Conference Report EHA 2023","volume":"64 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125928180","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
MRD-positive patients with FLT3-ITD AML may benefit from post-transplant gilteritinib mrd阳性FLT3-ITD AML患者可能受益于移植后吉替尼
Medicom Conference Report EHA 2023 Pub Date : 2023-08-02 DOI: 10.55788/04292040
Robert van den Heuvel
{"title":"MRD-positive patients with FLT3-ITD AML may benefit from post-transplant gilteritinib","authors":"Robert van den Heuvel","doi":"10.55788/04292040","DOIUrl":"https://doi.org/10.55788/04292040","url":null,"abstract":"","PeriodicalId":196013,"journal":{"name":"Medicom Conference Report EHA 2023","volume":"47 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129179302","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Zandelisib promising in relapsed/refractory indolent B-cell NHL Zandelisib有望治疗复发/难治性惰性b细胞NHL
Medicom Conference Report EHA 2023 Pub Date : 2023-08-02 DOI: 10.55788/9c9d759a
Robert van den Heuvel
{"title":"Zandelisib promising in relapsed/refractory indolent B-cell NHL","authors":"Robert van den Heuvel","doi":"10.55788/9c9d759a","DOIUrl":"https://doi.org/10.55788/9c9d759a","url":null,"abstract":"","PeriodicalId":196013,"journal":{"name":"Medicom Conference Report EHA 2023","volume":"10 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126803092","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
QUIWI: First results suggest a clinical benefit of quizartinib in AML QUIWI:初步结果表明quizartinib对AML有临床益处
Medicom Conference Report EHA 2023 Pub Date : 2023-08-02 DOI: 10.55788/3cec284a
Robert van den Heuvel
{"title":"QUIWI: First results suggest a clinical benefit of quizartinib in AML","authors":"Robert van den Heuvel","doi":"10.55788/3cec284a","DOIUrl":"https://doi.org/10.55788/3cec284a","url":null,"abstract":"","PeriodicalId":196013,"journal":{"name":"Medicom Conference Report EHA 2023","volume":"36 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129356319","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Deep responses with asciminib in CML-CP   阿西米尼对CML-CP的深度响应
Medicom Conference Report EHA 2023 Pub Date : 2023-08-02 DOI: 10.55788/ca07c1a0
Robert van den Heuvel
{"title":"Deep responses with asciminib in CML-CP  ","authors":"Robert van den Heuvel","doi":"10.55788/ca07c1a0","DOIUrl":"https://doi.org/10.55788/ca07c1a0","url":null,"abstract":"","PeriodicalId":196013,"journal":{"name":"Medicom Conference Report EHA 2023","volume":"14 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129987971","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
High risk of death for individuals with C282Y/C282Y hereditary haemochromatosis and diabetes C282Y/C282Y遗传性血色素病和糖尿病患者死亡风险高
Medicom Conference Report EHA 2023 Pub Date : 2023-08-02 DOI: 10.55788/26b3af7c
Robert van den Heuvel
{"title":"High risk of death for individuals with C282Y/C282Y hereditary haemochromatosis and diabetes","authors":"Robert van den Heuvel","doi":"10.55788/26b3af7c","DOIUrl":"https://doi.org/10.55788/26b3af7c","url":null,"abstract":"","PeriodicalId":196013,"journal":{"name":"Medicom Conference Report EHA 2023","volume":"13 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121120209","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
EHA 2023 Highlights Podcast EHA 2023亮点播客
Medicom Conference Report EHA 2023 Pub Date : 2023-06-28 DOI: 10.55788/1005f52a
Robert van den Heuvel
{"title":"EHA 2023 Highlights Podcast","authors":"Robert van den Heuvel","doi":"10.55788/1005f52a","DOIUrl":"https://doi.org/10.55788/1005f52a","url":null,"abstract":"","PeriodicalId":196013,"journal":{"name":"Medicom Conference Report EHA 2023","volume":"24 7","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-06-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"113956917","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书